Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

NCI Community Oncology Research Program (NCORP)

NCI Community Oncology Research Program  (NCORP)


Network Components

NCORP consists of three components: Research Bases, Community Sites, and Minority/Underserved Community Sites.

Research Bases

Up to seven Research Bases will serve as NCORP research hubs to design and conduct multi-center cancer prevention, control and screening/post-treatment surveillance clinical trials and cancer care delivery research (CCDR).

Research Bases will be located at leading institutions with comprehensive expertise in cancer clinical trials. They will possess established organizational structures for designing and conducting multi-center clinical trials and CCDR studies including administration, data management, scientific and statistical leadership, study operational processes and personnel, and regulatory compliance. They will collaborate with other NCORP Research Bases and NCI, participate in the CCDR coordinating committee, and engage extramural researchers' participation.

Community Sites

Up to 40 Community Sites will accrue participants to trials conducted by NCORP Research Bases; NCTN treatment and imaging trials and quality of life studies; and CCDR including comparative effectiveness research, studies involving patients, practitioners and/or healthcare organizations via a consortium of community hospitals and/or oncology practices or community-based integrated healthcare systems.

Community Sites will accrue a minimum of 80 new participants annually, evenly distributed over trials/studies in cancer prevention and control, treatment, imaging, screening, and post-treatment surveillance. They will engage community partners and support CCDR studies in at least one component site.

Minority/Underserved Community Sites

Up to 14 Minority/Underserved Community Sites will accrue participants to trials conducted by NCORP Research Bases; NCI NCTN treatment and imaging trials and quality of life studies; and CCDR including comparative effectiveness research, studies involving patients, practitioners and/or healthcare organizations via a consortium of community hospitals and/or oncology practices, public hospitals, integrated healthcare systems, academic medical centers, or an NCI-designated Cancer Center.

Minority/Underserved Community Sites will have a patient population comprising at least 30% racial/ethnic minorities or rural residents, and will accrue a minimum of 80 new participants annually, evenly distributed over trials/studies in cancer prevention and control, treatment, imaging, screening, and post-treatment surveillance. They will engage community partners and support CCDR studies in at least one component site.

NCORP Organizational Structure Chart


Diagram of the NCORP organizational structure. Clinical Trials and Translational Research Advisory Committee (CTAC) Division of Cancer Control and Population Sciences (DCCPS) Division of Cancer Prevention (DCP) NCORP National Clinical Trials Network (NCTN) Center to Reduce Center Health Disparities (CRCHD) Division of Cancer Treatment and Diagnosis (DCTD) Central Institution Review Board (CIRB) Cancer Trials Support Unit (CTSU)


Last updated: Monday, May 19, 2014


Back to top